Effects of the angiotensin receptor blocker olmesartan on adipocyte hypertrophy and function in mice with metabolic disorders

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Maeda, Akinobu ^a   Tamura, Kouichi ^a   Wakui, Hiromichi ^a   Ohsawa, Masato ^a   Azushima, Kengo ^a   Uneda, Kazushi ^a   Kanaoka, Tomohiko ^a   Kobayashi, Ryu ^a   Ohki, Kohji ^a   Matsuda, Miyuki ^a   Tsurumi Ikeya, Yuko ^a   Yamashita, Akio ^a   Tokita, Yasuo ^b   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b FUJISAWA CITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ASSOCIATED PROTEIN; INTERLEUKIN 6; OLMESARTAN; UNCLASSIFIED DRUG; ANGIOTENSIN RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADIPOCYTE HYPERTROPHY; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CELL FUNCTION; CELLULAR PARAMETERS; CONTROLLED STUDY; DRUG INHIBITION; GENE EXPRESSION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PLEIOTROPY; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; ADIPOCYTE; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERTROPHY; METABOLIC DISEASES; OBESITY, ABDOMINAL; PATHOLOGY;

ADIPOCYTES; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; IMIDAZOLES; INTERLEUKIN-6; METABOLIC DISEASES; MICE; OBESITY, ABDOMINAL; TETRAZOLES;

EID: 84903641131     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/946492     Document Type: Article

References (50)

1. Reis J. P., Loria C. M., Lewis C. E., Powell-Wiley T. M., Wei G. S., Carr J. J., Terry J. G., Liu K., Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. Journal of the American Medical Association 2013 310 3 280 288 2-s2.0-84880282090 10.1001/jama.2013.7833
2. Maury E., Brichard S. M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology 2010 314 1 1 16 2-s2.0-70350188297 10.1016/j.mce.2009.07.031
3. Hajer G. R., van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
4. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
5. Mattu H. S., Randeva H. S., Role of adipokines in cardiovascular disease. Journal of Endocrinology 2013 216 1 T17 T36 2-s2.0-84874430535 10.1530/JOE-12-0232
6. Yvan-Charvet L., Quignard-Boulangé A., Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney International 2011 79 2 162 168 2-s2.0-78650919357 10.1038/ki.2010.391
7. Jing F., Mogi M., Horiuchi M., Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction. Molecular and Cellular Endocrinology 2013 378 1-2 23 28 2-s2.0-84859205505 10.1016/j.mce.2012.03.005
8. Suto J.-I., Matsuura S., Imamura K., Yamanaka H., Sekikawa K., Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-A(y) mice. European Journal of Endocrinology 1998 139 6 654 661 2-s2.0-0032420530 10.1530/eje.0.1390654 (Pubitemid 29030406)
9. Iwai M., Kanno H., Tomono Y., Inaba S., Senba I., Furuno M., Mogi M., Horiuchi M., Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-Ay mice. Journal of Hypertension 2010 28 7 1471 1481 2-s2.0-77954386779 10.1097/HJH.0b013e32833bc420
10. Jing F., Mogi M., Min L.-J., Ohshima K., Nakaoka H., Tsukuda K., Wang X., Iwanami J., Horiuchi M., Effect of angiotensin II type 2 receptor-interacting protein on adipose tissue function via modulation of macrophage polarization. PLoS ONE 2013 8 4 2-s2.0-84875683178 10.1371/journal.pone.0060067 e60067
11. Lei B., Nakano D., Fan Y.-Y., Kitada K., Hitomi H., Kobori H., Mori H., Masaki T., Nishiyama A., Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan. Journal of Pharmacological Sciences 2012 119 2 131 138 2-s2.0-84863103139 10.1254/jphs.12031FP
12. Maeda A., Tamura K., Wakui H., Ohsawa M., Azushima K., Uneda K., Kobayashi R., Tsurumi-Ikeya Y., Kanaoka T., Dejima T., Ohki K., Haku S., Yamashita A., Umemura S., Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders. International Journal of Medical Sciences 2014 11 6 646 651 10.7150/ijms.8577
13. 2+ exchanger type-1 in vascular smooth muscle. Nature Medicine 2004 10 11 1193 1199 2-s2.0-9144275007 10.1038/nm1118 (Pubitemid 39540435)
14. Tsurumi Y., Tamura K., Tanaka Y., Koide Y., Sakai M., Yabana M., Noda Y., Hashimoto T., Kihara M., Hirawa N., Toya Y., Kiuchi Y., Iwai M., Horiuchi M., Umemura S., Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules. Kidney International 2006 69 3 488 494 2-s2.0-31544462099 10.1038/sj.ki.5000130 (Pubitemid 43164440)
15. Wakui H., Tamura K., Matsuda M., Bai Y., Dejima T., Shigenaga A.-I., Masuda S.-I., Azuma K., Maeda A., Hirose T., Ishigami T., Toya Y., Yabana M., Minamisawa S., Umemura S., Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. American Journal of Physiology: Renal Physiology 2010 299 5 F991 F1003 2-s2.0-78349251640 10.1152/ajprenal.00738.2009
16. Matsuda M., Tamura K., Wakui H., Maeda A., Ohsawa M., Kanaoka T., Azushima K., Uneda K., Haku S., Tsurumi-Ikeya Y., Toya Y., Maeshima Y., Yamashita A., Umemura S., Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein. Journal of Biological Chemistry 2013 288 26 19238 19249 2-s2.0-84879576940 10.1074/jbc.M113.451054
17. Wakui H., Tamura K., Tanaka Y., Matsuda M., Bai Y., Dejima T., Masuda S.-I., Shigenaga A.-I., Maeda A., Mogi M., Ichihara N., Kobayashi Y., Hirawa N., Ishigami T., Toya Y., Yabana M., Horiuchi M., Minamisawa S., Umemura S., Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 2010 55 5 1157 1164 2-s2.0-77951499906 10.1161/ HYPERTENSIONAHA.109.147207
18. Wakui H., Tamura K., Masuda S.-I., Tsurumi-Ikeya Y., Fujita M., Maeda A., Ohsawa M., Azushima K., Uneda K., Matsuda M., Kitamura K., Uchida S., Toya Y., Kobori H., Nagahama K., Yamashita A., Umemura S., Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension 2013 61 6 1203 1210 2-s2.0-84878926483 10.1161/HYPERTENSIONAHA.111.00572
19. Maeda A., Tamura K., Wakui H., Dejima T., Ohsawa M., Azushima K., Kanaoka T., Uneda K., Matsuda M., Yamashita A., Miyazaki N., Yatsu K., Hirawa N., Toya Y., Umemura S., Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity. Journal of the American Heart Association 2013 2 4 e000312 10.1161/JAHA.113.000312
20. Apovian C. M., Bigornia S., Mott M., Meyers M. R., Ulloor J., Gagua M., McDonnell M., Hess D., Joseph L., Gokce N., Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1654 1659 2-s2.0-51649088497 10.1161/ATVBAHA.108.170316
21. Neels J. G., Olefsky J. M., Inflamed fat: what starts the fire? Journal of Clinical Investigation 2006 116 1 33 35 2-s2.0-31044447347 10.1172/JCI27280 (Pubitemid 43121788)
22. Schenk S., Saberi M., Olefsky J. M., Insulin sensitivity: modulation by nutrients and inflammation. Journal of Clinical Investigation 2008 118 9 2992 3002 2-s2.0-51349156218 10.1172/JCI34260
23. Osborn O., Olefsky J. M., The cellular and signaling networks linking the immune system and metabolism in disease. Nature Medicine 2012 18 3 363 374 2-s2.0-84857985148 10.1038/nm.2627
24. Sell H., Habich C., Eckel J., Adaptive immunity in obesity and insulin resistance. Nature Reviews Endocrinology 2012 8 12 709 716 2-s2.0-84870058819 10.1038/nrendo.2012.114
25. Fullerton M. D., Steinberg G. R., Schertzer J. D., Immunometabolism of AMPK in insulin resistance and atherosclerosis. Molecular and Cellular Endocrinology 2013 366 2 224 234 2-s2.0-84872660747 10.1016/j.mce.2012.02.004
26. Ferrante A. W. Jr., Macrophages, fat, and the emergence of immunometabolism. Journal of Clinical Investigation 2013 123 12 4992 4993 10.1172/JCI73658
27. Tabata M., Kadomatsu T., Fukuhara S., Miyata K., Ito Y., Endo M., Urano T., Zhu H. J., Tsukano H., Tazume H., Kaikita K., Miyashita K., Iwawaki T., Shimabukuro M., Sakaguchi K., Ito T., Nakagata N., Yamada T., Katagiri H., Kasuga M., Ando Y., Ogawa H., Mochizuki N., Itoh H., Suda T., Oike Y., Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metabolism 2009 10 3 178 188 2-s2.0-69149090011 10.1016/j.cmet.2009.08.003
28. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 8 941 946 2-s2.0-17944365228 10.1038/90984 (Pubitemid 32756432)
29. Kadowaki T., Yamauchi T., Adiponectin receptor signaling: a new layer to the current model. Cell Metabolism 2011 13 2 123 124 2-s2.0-79551539872 10.1016/j.cmet.2011.01.012
30. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., Matsuzawa Y., PPAR γ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001 50 9 2094 2099 2-s2.0-0035462629 (Pubitemid 33643677)
31. Lazar M. A., The humoral side of insulin resistance. Nature Medicine 2006 12 1 43 44 2-s2.0-30044431861 10.1038/nm0106-43 (Pubitemid 43050062)
32. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I., Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation 2004 114 12 1752 1761 2-s2.0-15244342531 10.1172/JCI200421625 (Pubitemid 40385531)
33. Roberts C. K., Barnard R. J., Sindhu R. K., Jurczak M., Ehdaie A., Vaziri N. D., Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism: Clinical and Experimental 2006 55 7 928 934 2-s2.0-33745138155 10.1016/j.metabol.2006.02.022 (Pubitemid 43902895)
34. Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González Á., Esquivel-Chirino C., Durante-Montiel I., Sánchez-Rivera G., Valadez-Vega C., Morales-González J. A., Inflammation, oxidative stress, and obesity. International Journal of Molecular Sciences 2011 12 5 3117 3132 2-s2.0-79957805810 10.3390/ijms12053117
35. Hahn W. S., Kuzmicic J., Burrill J. S., Donoghue M. A., Foncea R., Jensen M. D., Lavandero S., Arriaga E. A., Bernlohr D. A., Pro-inflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress and dynamics. American Journal of Physiology: Endocrinology and Metabolism 2014 306 9 E1033 E1045 10.1152/ajpendo.00422.2013
36. Zhang G.-X., Lu X.-M., Kimura S., Nishiyama A., Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovascular Research 2007 76 2 204 212 2-s2.0-36649037377 10.1016/j.cardiores.2007.07.014 (Pubitemid 350198600)
37. Bae Y. S., Oh H., Rhee S. G., Yoo Y. D., Regulation of reactive oxygen species generation in cell signaling. Molecules and Cells 2011 32 6 491 509 2-s2.0-84859897794 10.1007/s10059-011-0276-3
38. Lassègue B., San Martín A., Griendling K. K., Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circulation Research 2012 110 10 1364 1390 2-s2.0-84861062943 10.1161/CIRCRESAHA.111.243972
39. Schramm A., Matusik P., Osmenda G., Guzik T. J., Targeting NADPH oxidases in vascular pharmacology. Vascular pharmacology 2012 56 5-6 216 231 2-s2.0-84866183230
40. Azuma K., Tamura K., Shigenaga A.-I., Wakui H., Masuda S.-I., Tsurumi-Ikeya Y., Tanaka Y., Sakai M., Matsuda M., Hashimoto T., Ishigami T., Lopez-Ilasaca M., Umemura S., Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension 2007 50 5 926 932 2-s2.0-35848955412 10.1161/HYPERTENSIONAHA.107.096115 (Pubitemid 350287536)
41. Tanaka Y., Tamura K., Koide Y., Sakai M., Tsurumi Y., Noda Y., Umemura M., Ishigami T., Uchino K., Kimura K., Horiuchi M., Umemura S., The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Letters 2005 579 7 1579 1586 2-s2.0-20044378313 10.1016/j.febslet.2005.01.068 (Pubitemid 40341526)
42. Wakui H., Dejima T., Tamura K., Uneda K., Azuma K., Maeda A., Ohsawa M., Kanaoka T., Azushima K., Kobayashi R., Matsuda M., Yamashita A., Umemura S., Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovascular Research 2013 100 3 511 519 10.1093/cvr/cvt225
43. Horiuchi M., Iwanami J., Mogi M., Regulation of angiotensin II receptors beyond the classical pathway. Clinical Science 2012 123 4 193 203 2-s2.0-84862322861 10.1042/CS20110677
44. Mogi M., Iwai M., Horiuchi M., Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2532 2539 2-s2.0-36348982705 10.1161/ATVBAHA.107.144154 (Pubitemid 350158902)
45. Tamura K., Tanaka Y., Tsurumi Y., Azuma K., Shigenaga A.-I., Wakui H., Masuda S.-I., Matsuda M., The role of angiotensin AT1 receptor associated protein in renin-angiotensin system regulation and function. Current Hypertension Reports 2007 9 2 121 127 2-s2.0-34249100267 10.1007/s11906-007- 0022-6 (Pubitemid 46779376)
46. Tamura K., Wakui H., Maeda A., Dejima T., Ohsawa M., Azushima K., Kanaoka T., Haku S., Uneda K., Masuda S. I., Azuma K., Shigenaga A. I., Koide Y., Tsurumi-Ikeya Y., Matsuda M., Toya Y., Tokita Y., Yamashita A., Umemura S., The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap. Current Pharmaceutical Design 2013 19 17 3043 3048 10.2174/1381612811319170010
47. Shigenaga A.-I., Tamura K., Wakui H., Masuda S.-I., Azuma K., Tsurumi-Ikeya Y., Ozawa M., Mogi M., Matsuda M., Uchino K., Kimura K., Horiuchi M., Umemura S., Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule. Hypertension 2008 52 4 672 678 2-s2.0-54749158191 10.1161/HYPERTENSIONAHA.108.117341
48. Dejima T., Tamura K., Wakui H., Maeda A., Ohsawa M., Kanaoka T., Haku S., Kengo A., Masuda S.-I., Shigenaga A.-I., Azuma K., Matsuda M., Yabana M., Hirose T., Uchino K., Kimura K., Nagashima Y., Umemura S., Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats. Journal of Hypertension 2011 29 10 1919 1929 2-s2.0-84856018733 10.1097/HJH.0b013e32834a5a46
49. Rodriguez R., Viscarra J. A., Minas J. N., Nakano D., Nishiyama A., Ortiz R. M., Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome. Endocrinology 2012 153 4 1684 1695 2-s2.0-84859393335 10.1210/en.2011-1885
50. Kurata A., Nishizawa H., Kihara S., Maeda N., Sonoda M., Okada T., Ohashi K., Hibuse T., Fujita K., Yasui A., Hiuge A., Kumada M., Kuriyama H., Shimomura I., Funahashi T., Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney International 2006 70 10 1717 1724 2-s2.0-33750604403 10.1038/sj.ki.5001810 (Pubitemid 44684802)